Clostridium Difficile Infection – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030
Clostridioides difficile (C. diff ) is a germ (bacteria) that causes life-threatening diarrhea. It is usually a side-effect of taking antibiotics. Etiology- Clostridium difficile infection (CDI) is a toxin-producing bacteria that causes a more severe form of antibiotic-associated diarrhea. The disease ranges from mild diarrhea to severe colon inflammation that can even be fatal. This bacterium is everywhere in the environment and produces spores that are hard to get rid of. C. difficile produces two main toxins - toxins A and B - that cause inflammation in the colon. Epidemiology- It’s estimated to cause almost half a million infections in the United States each year. The competitive landscape of Clostridium Difficile Infection includes country-specific approved and pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are tracked and supplemented with analyst commentary. KOLs insights of Clostridium Difficile Infection across 8 MM m...